1-8 of 8
Gerrard Teoh, MD
Close
Sort by
Journal Articles

Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study

Jae Hoon Lee, Kihyun Kim, MD, Jin Seok Kim, Chang Ki Min, MD, Sung-Soo Yoon, MD, Kazuyuki Shimizu, MD, Takaaki Chou, MD, Hiroshi Kosugi, MD, Kenshi Suzuki, MD, PhD, Hiroyuki Hata, MD, PhD, Wenming Chen, MD, Jian Hou, MD, PhD, Jin Lu, MD, Shang-Yi Huang, MD, PhD, Wee-Joo Chng, MD, Daryl Tan, MD, Gerrard Teoh, MD, James Chor Sang Chim, MD, Noppadol Siritanaratkul, MD, Weerasak Nawarawong, MD, Brian GM Durie, MD
Journal: Blood
Blood (2012) 120 (21): 5035.
https://doi.org/10.1182/blood.V120.21.5035.5035
Published: 2012
Journal Articles

Protein Mapping and Characterization of Post-Translational Modifications of Ku86 Protein Variants in Multiple Myeloma Cell Lines.

Geraline Cow, BSc, Charles Gullo, PhD, Feng Ge, MSc, Gerrard Teoh, MD
Journal: Blood
Blood (2006) 108 (11): 3510.
https://doi.org/10.1182/blood.V108.11.3510.3510
Published: 2006
Journal Articles

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD
Journal: Blood
Blood (2006) 108 (11): 5097.
https://doi.org/10.1182/blood.V108.11.5097.5097
Published: 2006
Journal Articles

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD
Journal: Blood
Blood (2006) 108 (11): 5100.
https://doi.org/10.1182/blood.V108.11.5100.5100
Published: 2006
Journal Articles

The Biochemical Characterization of Three Forms of Ku86 Protein in Multiple Myeloma Cell Lines.

Charles A. Gullo, PhD, Feng Ge, MSc, Geraline Cow, Dip, Gerrard Teoh, MD
Journal: Blood
Blood (2005) 106 (11): 3416.
https://doi.org/10.1182/blood.V106.11.3416.3416
Published: 2005
Journal Articles

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD
Journal: Blood
Blood (2005) 106 (11): 5127.
https://doi.org/10.1182/blood.V106.11.5127.5127
Published: 2005
Journal Articles

Decoupling of Normal CD40 / Interleukin-4 Immunoglobulin Heavy Chain Switch Signal Leads to Genomic Instability in RPMI 8226 and SGH-MM5 Multiple Myeloma Cell Lines.

William Hwang, MD, Charles Gullo, PhD, Gerrard Teoh, MD
Journal: Blood
Blood (2004) 104 (11): 1424.
https://doi.org/10.1182/blood.V104.11.1424.1424
Published: 2004
Journal Articles

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Gerrard Teoh, MD, William Hwang, MD, Liang Piu Koh, MD, Mickey Koh, MD, Daryl Tan, MD, Charles Gullo, PhD
Journal: Blood
Blood (2004) 104 (11): 4915.
https://doi.org/10.1182/blood.V104.11.4915.4915
Published: 2004